Y Mabs Therapeutics Stock Price Prediction

YMAB Stock  USD 10.38  0.19  1.80%   
The RSI of Y MAbs' share price is below 30 at the present time. This entails that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Y mAbs Therapeutics, making its price go up or down.

Oversold Vs Overbought

25

 
Oversold
 
Overbought
The successful prediction of Y MAbs' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Y mAbs Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Y MAbs' stock price prediction:
EPS Estimate Next Quarter
(0.13)
EPS Estimate Current Year
(0.57)
EPS Estimate Next Year
(0.49)
Wall Street Target Price
21
EPS Estimate Current Quarter
(0.16)
Using Y MAbs hype-based prediction, you can estimate the value of Y mAbs Therapeutics from the perspective of Y MAbs response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Y MAbs using Y MAbs' stock options and short interest. It helps to benchmark the overall future attitude of investors towards YMAB using crowd psychology based on the activity and movement of Y MAbs' stock price.

Y MAbs Implied Volatility

    
  0.85  
Y MAbs' implied volatility exposes the market's sentiment of Y mAbs Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Y MAbs' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Y MAbs stock will not fluctuate a lot when Y MAbs' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Y MAbs to buy its stock at a price that has no basis in reality. In that case, they are not buying YMAB because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Y MAbs after-hype prediction price

    
  USD 11.04  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Y MAbs Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
6.6410.5714.50
Details
Naive
Forecast
LowNextHigh
8.3412.2716.21
Details
9 Analysts
Consensus
LowTargetHigh
11.3112.4313.80
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.21-0.14-0.05
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Y MAbs. Your research has to be compared to or analyzed against Y MAbs' peers to derive any actionable benefits. When done correctly, Y MAbs' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Y mAbs Therapeutics.

Y MAbs After-Hype Price Prediction Density Analysis

As far as predicting the price of Y MAbs at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Y MAbs or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Y MAbs, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Y MAbs Estimiated After-Hype Price Volatility

In the context of predicting Y MAbs' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Y MAbs' historical news coverage. Y MAbs' after-hype downside and upside margins for the prediction period are 7.11 and 14.97, respectively. We have considered Y MAbs' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
10.38
11.04
After-hype Price
14.97
Upside
Y MAbs is somewhat reliable at this time. Analysis and calculation of next after-hype price of Y mAbs Therapeutics is based on 3 months time horizon.

Y MAbs Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Y MAbs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Y MAbs backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Y MAbs, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.39 
3.93
  0.66 
  0.07 
8 Events / Month
19 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
10.38
11.04
6.36 
233.93  
Notes

Y MAbs Hype Timeline

Y mAbs Therapeutics is at this time traded for 10.38. The entity has historical hype elasticity of 0.66, and average elasticity to hype of competition of -0.07. YMAB is forecasted to increase in value after the next headline, with the price projected to jump to 11.04 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 6.36%, whereas the daily expected return is at this time at -0.39%. The volatility of related hype on Y MAbs is about 2082.12%, with the expected price after the next announcement by competition of 10.31. The company has Profit Margin (PM) of (0.28) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.43) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.43. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days.
Check out Y MAbs Basic Forecasting Models to cross-verify your projections.

Y MAbs Related Hype Analysis

Having access to credible news sources related to Y MAbs' direct competition is more important than ever and may enhance your ability to predict Y MAbs' future price movements. Getting to know how Y MAbs' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Y MAbs may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
TCRRTcr2 Therapeutics 0.06 8 per month 3.26  0.05  5.77 (6.25) 43.60 
RVMDRevolution Medicines 1.10 10 per month 3.03  0.04  4.81 (5.31) 16.40 
BDTXBlack Diamond Therapeutics(0.07)7 per month 0.00 (0.31) 5.47 (8.30) 19.51 
BCELAtreca Inc 0.00 0 per month 5.00  0.02  7.53 (9.65) 23.80 
PASGPassage Bio(0.02)8 per month 6.33  0.07  12.07 (10.67) 79.28 
BLUEBluebird bio(0.01)9 per month 0.00 (0.09) 7.89 (9.62) 23.25 
MRSNMersana Therapeutics 0.22 9 per month 5.02  0.11  12.03 (9.72) 32.25 
ZNTLZentalis Pharmaceuticals Llc 0.15 9 per month 5.29  0.0006  11.41 (8.64) 33.76 
TVTXTravere Therapeutics(0.30)10 per month 1.95  0.24  11.58 (4.13) 23.97 
GBIOGeneration Bio Co 0.21 5 per month 0.00 (0.19) 9.35 (8.20) 25.48 
KRONKronos Bio(0.04)9 per month 0.00 (0.08) 5.56 (6.25) 16.20 
ERASErasca Inc 0.21 7 per month 3.60  0.02  7.42 (5.19) 17.38 
CCCCC4 Therapeutics 0.02 9 per month 0.00 (0.13) 8.59 (7.98) 23.66 
EWTXEdgewise Therapeutics 1.60 10 per month 2.78  0.12  6.65 (4.64) 61.02 
ARQTArcutis Biotherapeutics(0.48)8 per month 3.34  0.04  7.00 (5.44) 16.11 
ICVXIcosavax(0.11)1 per month 4.56  0.13  10.22 (6.79) 38.57 
MIRMMirum Pharmaceuticals(1.72)9 per month 2.27 (0.0003) 3.88 (4.18) 12.25 
VECTVectivBio Holding AG 0.06 7 per month 0.88  0.19  5.61 (3.08) 39.30 
DAWNDay One Biopharmaceuticals 0.27 10 per month 2.71 (0.04) 3.84 (3.69) 11.44 
PCVXVaxcyte(3.63)9 per month 2.24  0.03  3.32 (4.09) 42.81 
LRMRLarimar Therapeutics(0.36)7 per month 0.00 (0.06) 10.87 (9.55) 26.71 
SNDXSyndax Pharmaceuticals(1.08)10 per month 0.00 (0.08) 4.02 (4.33) 34.00 
MRUSMerus BV(0.74)8 per month 0.00 (0.1) 3.33 (3.83) 10.85 
STROSutro Biopharma 0.13 5 per month 0.00 (0.14) 7.81 (8.71) 30.73 

Y MAbs Additional Predictive Modules

Most predictive techniques to examine YMAB price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for YMAB using various technical indicators. When you analyze YMAB charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Y MAbs Predictive Indicators

The successful prediction of Y MAbs stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Y mAbs Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Y MAbs based on analysis of Y MAbs hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Y MAbs's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Y MAbs's related companies.
 2022 2023 2024 (projected)
Days Sales Outstanding70.0896.6365.97
PTB Ratio1.952.952.8

Story Coverage note for Y MAbs

The number of cover stories for Y MAbs depends on current market conditions and Y MAbs' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Y MAbs is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Y MAbs' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Y MAbs Short Properties

Y MAbs' future price predictability will typically decrease when Y MAbs' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Y mAbs Therapeutics often depends not only on the future outlook of the potential Y MAbs' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Y MAbs' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding43.6 M
Cash And Short Term Investments78.6 M

Complementary Tools for YMAB Stock analysis

When running Y MAbs' price analysis, check to measure Y MAbs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Y MAbs is operating at the current time. Most of Y MAbs' value examination focuses on studying past and present price action to predict the probability of Y MAbs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Y MAbs' price. Additionally, you may evaluate how the addition of Y MAbs to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Global Correlations
Find global opportunities by holding instruments from different markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios